Genting-run Universal Studios Singapore fully booked

(theedgemarkets.com / December 29, 2020 16:55 pm +08)


KUALA LUMPUR (Dec 29): Genting Bhd’s 52.66%-owned subsidiary Genting Singapore Ltd’s operating unit Resorts World Sentosa (RWS) said the Universal Studios Singapore theme park within RWS has reached capacity for Thursday (Dec 31) and Friday (Jan 1, 2021).

Meanwhile, RWS' S.E.A. Aquarium has reached capacity for today and tomorrow, according to a notice on RWS’ website.

"We encourage you to select another date to visit,” RWS said in the notice to potential visitors.

RWS’ notice coincides with the start of Singapore's Phase 3 reopening since yesterday at a time when the global community is still contending with the economic impact of the Covid-19 pandemic driven restricted movement policies to curb the outbreak.

It was reported that following Singapore’s exit from a two-month-long Covid-19-driven circuit breaker on June 1, authorities said the island nation would reopen in three phases.

"Phase 2 started on June 19, and the Covid-19 task force had said in October that Phase 3 could begin before the end of the year,” CNA reported on Dec 14.


## https://www.theedgemarkets.com/article/gentingrun-universal-studios-singapore-fully-booked

UK expected to approve Oxford-AstraZeneca Covid vaccine this week

(PUBLISHED MON, DEC 28 20206:52 AM EST)

~ The AstraZeneca shot would be rolled out next week if approved in the next few days.

~ It would be added to the Pfizer-BioNTech vaccine, which has been given to 600,000 in the U.K., according to government statistics.


LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is expected to be approved for use in the U.K. in coming days.

The Financial Times reported Sunday that government officials confirmed that the Medicines and Healthcare products Regulatory Agency would imminently approve the vaccine, saying the announcement could come as soon as Tuesday. The Sunday Telegraph newspaper reported that the approval could come as early as Monday as health-care workers prepare to administer the shots.

But the regulator has been tight lipped on the move, and the U.K.’s Department of Health told Reuters the agency should be given time to properly assess the data from the vaccine’s trials.

Cabinet minister Michael Gove also gave nothing away in media interviews on Monday morning but said its approval could accelerate the lifting of strict lockdowns in the country, which have effectively canceled Christmas festivities for many millions.

Around 30,500 daily infections and 316 deaths were recorded in the U.K. on Sunday, but those figures could be understated due to reporting delays. Cases have surged in London and south England, raising pressure on hospitals. A new coronavirus variant found in the U.K. is reportedly more transmissible and has led to travel restrictions for people wanting to leave the country.

The AstraZeneca shot would likely be rolled out next week if approved in the next few days and would be added to the Pfizer-BioNTech vaccine, which has so far been given to 600,000 in the U.K., according to government statistics.

The Oxford-AstraZeneca candidate would allow the country to significantly ramp up its inoculation program, given its development in the U.K. It’s also much cheaper than others and does not need to be kept at ultra-low temperatures.

Earlier this month, Dr. Richard Horton, editor-in-chief of The Lancet medical journal, told CNBC the vaccine could be used around the globe more effectively than others.

“The Oxford/AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have,” Horton said, adding that it was important to think about vaccine immunization on a global scale “because even if we immunize one country, the threat then is you reintroduce the virus from another country that is not protected.”

Confusion around its trial data in November led to some criticism of U.K.-based AstraZeneca. The data suggests that the vaccine can help reduce the spread of Covid-19, as well as prevent illness and death. The study also found it had an effectiveness of 62% for trial participants given two full doses, but 90% for a subgroup given half a dose followed by a full dose.

But chief of the White House’s Operation Warp Speed, Moncef Slaoui, and others in the U.S. have expressed concern over the age group tested, saying the 90% efficacy was only shown for the lowest risk group, which numbered 2,741 people below age 55.

Pascal Soriot, CEO of AstraZeneca, said the pharmaceutical giant will run an additional global trial to evaluate the efficacy of its vaccine. Soriot told The Times newspaper this weekend he is convinced that subsequent data will show his company had achieved an efficacy rate equal to the others, at above 90%.

“We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else,” he said. “I can’t tell you more because we will publish at some point.”

He added that AstraZeneca believes the vaccine will be effective against the new strain of the coronavirus, but was running tests to confirm it.


## https://www.cnbc.com/2020/12/28/uk-expected-to-approve-oxford-astrazeneca-covid-vaccine-this-week.html

Money Heist ......

https://www.youtube.com/watch?v=HkjaFXNEcvE

Let Dance Monkey............

https://www.youtube.com/watch?v=q0hyYWKXF0Q

Wahhhh.....

Right now Topglove & Supermax moving at the same price....


Why lai that aahhh !!!!!!!!!!..........

Funstrat's Tom Lee expects the S&P 500 to rally in the second half of 2021 (Dec 17, 2020)

Tom Lee, Fundstrat Gobal Advisors managing partner and head of research, says he expects the S&P 500 to rally up to 4,300 in the second half of 2021. Jim Lebenthal, partner at Cerity Partners


## https://www.youtube.com/watch?v=QLp0kOgVunU

10 reasons why the S&P 500 will surge 7% into year-end, according to Fundstrat

(Nov. 19, 2020, 05:39 PM)

~ The S&P 500 has more room to run, according to a Thursday note from Fundstrat's Tom Lee.

~ Lee upped his year-end S&P 500 price target to 3,800 from 3,525, representing potential upside of 7% from Wednesday's close.

~ Here are 10 reasons why Lee expects the S&P 500 to continue its record climb over the next 6 weeks, according to the note.


The stock market's record post-election rally will continue into year-end, according to Fundstrat's Tom Lee.

In a note on Thursday, Lee upped his year-end S&P 500 price target to 3,800 from 3,525, representing potential upside of 7% from Wednesday's close.

Lee is not surprised to see stocks consolidate over the past few days, and understands why some investors might believe that stock market has become "overly exuberant."

But according to Lee, an expansion in earnings multiples could drive new gains over the next six weeks. In his note, he gives the 10 following reasons.

1. "COVID-19 vaccine and therapeutics take 'worst case [scenario]' off table."

2. "Policymakers are pursuing soft-lockdowns, not killing recovery."

3. "Pent-up demand is US, look at output gap."

4. "China seeing massive explosive economic recovery."

5. "Fiscal stimulus coming."

6. "Investors are cautiously positioned, with little conviction."

7. "$4.5 trillion cash on sidelines."

8. "If VIX breaks below 20, double-risk on signal."

9. "Santa Claus rally."

10. "Fed dovish."


"With tailwinds for P/E expansion, we see 2021 P/E rising to 19.7x from 18.3x, which would lead to S&P 500 3,800," Lee said, basing his target on estimates that the S&P 500 notches record EPS of $193 in 2021.

A 7% move higher into year-end is about the magnitude of a typical Santa Claus rally, "so we are saying markets see their typical seasonal gains" over the next six weeks, the note said.

And a P/E valuation multiple of 19.7x is not demanding for the S&P 500, considering that it's a discount to the current implied P/E multiple of high-yield bonds. High yield bonds are currently priced at an implied P/E multiple of 20.6x, Lee explained.

"If the S&P 500 traded at 20.6x, the S&P 500 would be 3,976," Lee said.

Year-to-date, the S&P 500 is up 10% as of Wednesday's close.


## https://markets.businessinsider.com/news/stocks/10-reasons-sp500-will-surge-into-year-end-fundstrat-says-2020-11-1029822041

No need write off....

Just write up....just write down enough......

If no crook...how to make victims money to pay Rakyat dividend...

Adui........

Santa Clause wouldn't come to Malaysia...

Malaysia weather too hot.....

Santa Clause tak boleh tahan too hot...

You see market......Everyday too hot until scaring Santa Clause come to Malaysia....

Japan’s Nikkei 225 surges to levels not seen since early 1990s; Asia-Pacific markets mixed

(PUBLISHED MON, DEC 28 20206:37 PM ESTUPDATED MON, DEC 28 202011:28 PM EST)

~ In Japan, the Nikkei 225 gained 1.96% — trading at levels not seen since August 1990 — according to data from Refinitiv.

~ The gains stateside came after U.S. President Donald Trump signed a $900 billion coronavirus relief package into law.


SINGAPORE — Stocks in Asia-Pacific were mixed in Tuesday trade following overnight gains on Wall Street that sent the major averages to record highs.

In Japan, the Nikkei 225 gained 1.96% — trading at levels not seen since August 1990, according to data from Refinitiv. Shares of index heavyweight Fast Retailing and conglomerate Softbank Group gained more than 3% each. The Topix index advanced 1.36%.

South Korea’s Kospi was fractionally lower.

Mainland Chinese stocks were lower by the afternoon, with the Shanghai composite down 0.33% while the Shenzhen component dipped 0.338%. Hong Kong’s Hang Seng index gained 1.05%.

Shares in Australia rose following their return from a Monday holiday, with the S&P/ASX 200 up 0.44%.

MSCI’s broadest index of Asia-Pacific shares outside Japan gained 0.47%.

Overnight on Wall Street, the Dow Jones Industrial Average gained 0.7% to close at 30,403.97. The S&P 500 rose 0.9% to finish its trading day at 3,735.36 while the Nasdaq Composite closed 0.7% higher at 12,899.42.

The gains stateside came after U.S. President Donald Trump signed a $900 billion coronavirus relief package into law, with the measure including a direct payment of $600 to most Americans. Trump had previously demanded a $2,000 direct payment days before the signing. The House voted Monday to increase the second round of federal direct payments to $2,000, leaving it up to the GOP-controlled Senate.

Currencies and oil

The U.S. dollar index, which tracks the greenback against a basket of its peers, was at 90.11 following an earlier high of 90.227.

The Japanese yen traded at 103.65 per dollar after weakening yesterday from around the 103.4 level against the greenback. The Australian dollar changed hands at $0.7595, having slipped from levels above $0.76 yesterday.

Oil prices were higher in the afternoon of Asia trading hours, with international benchmark Brent crude futures up 0.47% to $51.10 per barrel. U.S. crude futures gained 0.52% to $47.87 per barrel.


## https://www.cnbc.com/2020/12/29/asia-markets-wall-street-us-stimulus-coronavirus-currencies.html

Mayday...Mayday....We are not falling down...We are not falling down...


Mayday...Mayday...We are half way falling down...We are half way falling down...

Of course their all win liao lahhh....

If not how can they pay you dividend lorrr.........



Posted by Happyday123 > Dec 29, 2020 12:22 PM | Report Abuse

IBs, fund managers and EPFs are the big winners than retail investors...How much tone of money as retail investors have and just hoping on downtrend on gloves counters...Smart retail investors won't tight up with their limited funds with gloves counters alone lo...

Let Dance Monkey............

https://www.youtube.com/watch?v=q0hyYWKXF0Q

Keyman188 is very broke & poor investor....


Keyman188 not professional or expertise....


Keyman188 always spend more time listen to Professionals & Expertise to avoid burning Keyman188 hard earned money....


Keyman188 very scared to become warrior or hero...


Keyman188 no harm better listen more to Professionals & Expertise to avoid become shark & crocodile victim...


-----------------------------------------------------------------------------------------------------------------------

Keyman188 not the professional or expertise...Let the expertise give more advise to the market...

为什么想投资科技股就必须关注美国大选最终结果？马股橱窗粉饰之后会有调整吗？ - 陈剑

##https://klse.i3investor.com/blogs/kianweiaritcles/2020-12-26-story-h1538398268.jsp


业绩这么好为何股价涨不动？近期手套股业绩和股价走势背离最完整讲解！- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-20-story-h1536526427.jsp


新冠疫苗面世后，股市里的聪明钱会去哪里？对手套板块有多大影响？- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-14-story-h1536429185.jsp

-----------------------------------------------------------------------------------------------------------------------


That's reason why some investment banks (IB) had started to revise glove sector outlook.........



Hereby to enclose the latest glove preview & outlook by IB...


Macquarie downgrades Top Glove to 'underperform', halves target price as earnings could normalise in 2H21

(theedgemarkets.com / September 10, 2020 17:36 pm +08)

##https://www.theedgemarkets.com/article/macquarie-downgrades-top-glove-underperform-halves-target-price-earnings-could-normalise




JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

(theedgemarkets.com / December 12, 2020 00:16 am +08)

##https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle




PublicInvest Research downgrades Top Glove to 'neutral' on ESG concerns

(theedgemarkets.com / December 18, 2020 10:38 am +08)

##https://www.theedgemarkets.com/article/publicinvest-research-downgrades-top-glove-neutral-esg-concerns



Revision :-

Macquarie - TP : 5.45

JP Morgan - TP : 3.50

PB IB - TP : 7.30

Keyman188 is very broke & poor investor....


Keyman188 not professional or expertise....


Keyman188 always spend more time listen to Professionals & Expertise to avoid burning Keyman188 hard earned money....


Keyman188 very scared to become warrior or hero...


Keyman188 no harm better listen more to Professionals & Expertise to avoid become shark & crocodile victim...

Keyman188 don't know lahhh....Keyman188 heard from "Sifu" said...

Glove sector will be volatility up & down...up & down...until mid of Jan'21....

Keyman188 tak tau lahhh....just listen Master said lorrrr....

Why music sudah stop !!!......


Let Dance Monkey............https://www.youtube.com/watch?v=q0hyYWKXF0Q

Keyman188 like this Ghost Busters..............


https://www.youtube.com/watch?v=m9We2XsVZfc

aiya....sometime become Hungry Ghost lorr....


Aiyou...sometime become Ghost Buster lorrr....

Aiya...Keyman188 very broke & poor investor mahhh....

Nothing to do then disturb sini disturb sana lorrr....

Mana bluechip super hot then pergi sana lorr....

Rumput lalang pun tak apa mahhh......



Posted by moneymakerx > Dec 29, 2020 10:20 AM | Report Abuse

keyman188. You have no worry on your HLCAP. but you are here to stir. because you want to see the world burn. Karma is real. there is no winner at the end of this trolling. Your post provide no value but self boasting, like the 99% of the naysayers here. same thing. No value, just to boast.

You all see Keyman188 favour stock....HLCap...

Everyday dropping like hell but Keyman188 no bising bising...

Keyman188 pegging its more drop to 3 /4 also can...

You know why??..........

This is called long term investor mahhh.....

Adui...........

Post removed.Why?

Keyman188 not the professional or expertise...Let the expertise give more advise to the market...

为什么想投资科技股就必须关注美国大选最终结果？马股橱窗粉饰之后会有调整吗？ - 陈剑

##https://klse.i3investor.com/blogs/kianweiaritcles/2020-12-26-story-h1538398268.jsp


业绩这么好为何股价涨不动？近期手套股业绩和股价走势背离最完整讲解！- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-20-story-h1536526427.jsp


新冠疫苗面世后，股市里的聪明钱会去哪里？对手套板块有多大影响？- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-14-story-h1536429185.jsp

-----------------------------------------------------------------------------------------------------------------


That's reason why some investment banks (IB) had started to revise glove sector outlook.........



Hereby to enclose the latest glove preview & outlook by IB...


Macquarie downgrades Top Glove to 'underperform', halves target price as earnings could normalise in 2H21

(theedgemarkets.com / September 10, 2020 17:36 pm +08)

##https://www.theedgemarkets.com/article/macquarie-downgrades-top-glove-underperform-halves-target-price-earnings-could-normalise




JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

(theedgemarkets.com / December 12, 2020 00:16 am +08)

##https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle




PublicInvest Research downgrades Top Glove to 'neutral' on ESG concerns

(theedgemarkets.com / December 18, 2020 10:38 am +08)

##https://www.theedgemarkets.com/article/publicinvest-research-downgrades-top-glove-neutral-esg-concerns



Revision :-

Macquarie - TP : 5.45

JP Morgan - TP : 3.50

PB IB - TP : 7.30



-----------------------------------------------------------------------------------------------------------------



Keyman188 comment is only for those need to heard & perceive...


Save your hard earned money to avoid fighting with Big Funds...


Sometime need to follow the "wind" where to come...where to blow....

UK expected to approve Oxford-AstraZeneca Covid vaccine this week

(PUBLISHED MON, DEC 28 20206:52 AM EST)

~ The AstraZeneca shot would be rolled out next week if approved in the next few days.

~ It would be added to the Pfizer-BioNTech vaccine, which has been given to 600,000 in the U.K., according to government statistics.


LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is expected to be approved for use in the U.K. in coming days.

The Financial Times reported Sunday that government officials confirmed that the Medicines and Healthcare products Regulatory Agency would imminently approve the vaccine, saying the announcement could come as soon as Tuesday. The Sunday Telegraph newspaper reported that the approval could come as early as Monday as health-care workers prepare to administer the shots.

But the regulator has been tight lipped on the move, and the U.K.’s Department of Health told Reuters the agency should be given time to properly assess the data from the vaccine’s trials.

Cabinet minister Michael Gove also gave nothing away in media interviews on Monday morning but said its approval could accelerate the lifting of strict lockdowns in the country, which have effectively canceled Christmas festivities for many millions.

Around 30,500 daily infections and 316 deaths were recorded in the U.K. on Sunday, but those figures could be understated due to reporting delays. Cases have surged in London and south England, raising pressure on hospitals. A new coronavirus variant found in the U.K. is reportedly more transmissible and has led to travel restrictions for people wanting to leave the country.

The AstraZeneca shot would likely be rolled out next week if approved in the next few days and would be added to the Pfizer-BioNTech vaccine, which has so far been given to 600,000 in the U.K., according to government statistics.

The Oxford-AstraZeneca candidate would allow the country to significantly ramp up its inoculation program, given its development in the U.K. It’s also much cheaper than others and does not need to be kept at ultra-low temperatures.

Earlier this month, Dr. Richard Horton, editor-in-chief of The Lancet medical journal, told CNBC the vaccine could be used around the globe more effectively than others.

“The Oxford/AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have,” Horton said, adding that it was important to think about vaccine immunization on a global scale “because even if we immunize one country, the threat then is you reintroduce the virus from another country that is not protected.”

Confusion around its trial data in November led to some criticism of U.K.-based AstraZeneca. The data suggests that the vaccine can help reduce the spread of Covid-19, as well as prevent illness and death. The study also found it had an effectiveness of 62% for trial participants given two full doses, but 90% for a subgroup given half a dose followed by a full dose.

But chief of the White House’s Operation Warp Speed, Moncef Slaoui, and others in the U.S. have expressed concern over the age group tested, saying the 90% efficacy was only shown for the lowest risk group, which numbered 2,741 people below age 55.

Pascal Soriot, CEO of AstraZeneca, said the pharmaceutical giant will run an additional global trial to evaluate the efficacy of its vaccine. Soriot told The Times newspaper this weekend he is convinced that subsequent data will show his company had achieved an efficacy rate equal to the others, at above 90%.

“We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else,” he said. “I can’t tell you more because we will publish at some point.”

He added that AstraZeneca believes the vaccine will be effective against the new strain of the coronavirus, but was running tests to confirm it.


## https://www.cnbc.com/2020/12/28/uk-expected-to-approve-oxford-astrazeneca-covid-vaccine-this-week.html

Keyman188 always like to repeat & repeat again to the market...


Keyman188 not professionals or expertise...


So we listen what professionals or expertise to guide us to avoid incur hard earned money......

Keyman188 not the professional or expertise...Let the expertise give more advise to the market...

 

为什么想投资科技股就必须关注美国大选最终结果？马股橱窗粉饰之后会有调整吗？ - 陈剑

##https://klse.i3investor.com/blogs/kianweiaritcles/2020-12-26-story-h1538398268.jsp

 

业绩这么好为何股价涨不动？近期手套股业绩和股价走势背离最完整讲解！- 陈剑

## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-20-story-h1536526427.jsp

 

新冠疫苗面世后，股市里的聪明钱会去哪里？对手套板块有多大影响？- 陈剑 ## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-14-story-h1536429185.jsp  

-----------------------------------------------------------------------------------------------------------------

 

That's reason why some investment banks (IB) had started to revise glove sector outlook.........

 

Hereby to enclose the latest glove preview & outlook by IB...

 

Macquarie downgrades Top Glove to 'underperform', halves target price as earnings could normalise in 2H21

(theedgemarkets.com / September 10, 2020 17:36 pm +08)

##https://www.theedgemarkets.com/article/macquarie-downgrades-top-glove-underperform-halves-target-price-earnings-could-normalise

 

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

(theedgemarkets.com / December 12, 2020 00:16 am +08)

##https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle

 

PublicInvest Research downgrades Top Glove to 'neutral' on ESG concerns

(theedgemarkets.com / December 18, 2020 10:38 am +08)

##https://www.theedgemarkets.com/article/publicinvest-research-downgrades-top-glove-neutral-esg-concerns

 

 
Revision :-

 
Macquarie - TP : 5.45

 
JP Morgan - TP : 3.50

 
PB IB - TP : 7.30

 

 
-----------------------------------------------------------------------------------------------------------------

 
Keyman188 comment is only for those need to heard & perceive...


Save your hard earned money to avoid fighting with Big Funds...

 
Sometime need to follow the "wind" where to come...where to blow....

Keyman188 preview current share price fair but not cheap (fair because consistent dividend payout to cover partial intrinsic value)...


You know why not cheap ???....Let Keyman188 give you some idea...


1) Based on latest financial result @ 30/09/20 (Q1'21) - Book value only RM 3.69, so the current share price against the book value is 1.72 times already exceeded financial sector average by 1.2 time


2) Despite book value gradually increased from RM 2.90 (2016) ~ RM 3.50 (2020), so the CAGR for the past 5 years was around 4.81%. If based on CAGR 4.81% to forecast next 5 years expected book value, shall be RM 4.43


3) Let see the intrinsic value, Keyman188 more prefer using every 5 years to forecast what is the upcoming value. If based on the CAGR 4.81%, average dividend payout for the past 5 years, so the intrinsic value shall be around RM 4.64 per share



## No matter using CAGR to forecast upcoming NTA (book value) or intrinsic value, the more safety margin to invest around the range of RM 4.43 ~ RM 4.64



Disclaimer : Above comment only Keyman188 personal preview & for personal reference

Post removed.Why?

Aiyo...like that HLCap mampus lorr....

HLEBroking under HLCap worrr....

So biz can be impacted ???................kekeke...kekeke....



Posted by alex > Dec 28, 2020 3:20 PM | Report Abuse

PLEASE BE INFORMED THAT OUR HLEBROKING TRADING SYSTEM/WEBSITE IS CURRENTLY EXPERIENCING TECHNICAL ISSUES.

OUR TEAM IS ACTIVELY WORKING TO FIX THE ISSUES. WE HOPE TO HAVE THIS RESOLVED SOON. THANK YOU FOR YOUR PATIENCE AND IF YOU ARE IMPACTED, PLEASE CHECK BACK HERE FOR UPDATES.

IN THE MEANTIME, PLEASE REFRAIN FROM TRADING ONLINE DURING THIS PERIOD. YOU MAY STILL TRADE OFFLINE AND CHECK YOUR SHARE BALANCE THROUGH YOUR REMISIER/DEALER REPRESENTATIVE

Bye2 hlebroking..

Aiyo...like that HLCap mampus lorr....

HLEBroking under HLCap worrr....

So biz can be impacted ???................kekeke...kekeke....



Posted by alex > Dec 28, 2020 3:20 PM | Report Abuse

PLEASE BE INFORMED THAT OUR HLEBROKING TRADING SYSTEM/WEBSITE IS CURRENTLY EXPERIENCING TECHNICAL ISSUES.

OUR TEAM IS ACTIVELY WORKING TO FIX THE ISSUES. WE HOPE TO HAVE THIS RESOLVED SOON. THANK YOU FOR YOUR PATIENCE AND IF YOU ARE IMPACTED, PLEASE CHECK BACK HERE FOR UPDATES.

IN THE MEANTIME, PLEASE REFRAIN FROM TRADING ONLINE DURING THIS PERIOD. YOU MAY STILL TRADE OFFLINE AND CHECK YOUR SHARE BALANCE THROUGH YOUR REMISIER/DEALER REPRESENTATIVE

Bye2 hlebroking..

Keyman188 not the professional or expertise...Let the expertise give more advise to the market...

为什么想投资科技股就必须关注美国大选最终结果？马股橱窗粉饰之后会有调整吗？ - 陈剑

##https://klse.i3investor.com/blogs/kianweiaritcles/2020-12-26-story-h1538398268.jsp


业绩这么好为何股价涨不动？近期手套股业绩和股价走势背离最完整讲解！- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-20-story-h1536526427.jsp


新冠疫苗面世后，股市里的聪明钱会去哪里？对手套板块有多大影响？- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-14-story-h1536429185.jsp

-----------------------------------------------------------------------------------------------------------------


That's reason why some investment banks (IB) had started to revise glove sector outlook.........



Hereby to enclose the latest glove preview & outlook by IB...


Macquarie downgrades Top Glove to 'underperform', halves target price as earnings could normalise in 2H21

(theedgemarkets.com / September 10, 2020 17:36 pm +08)

##https://www.theedgemarkets.com/article/macquarie-downgrades-top-glove-underperform-halves-target-price-earnings-could-normalise




JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

(theedgemarkets.com / December 12, 2020 00:16 am +08)

##https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle




PublicInvest Research downgrades Top Glove to 'neutral' on ESG concerns

(theedgemarkets.com / December 18, 2020 10:38 am +08)

##https://www.theedgemarkets.com/article/publicinvest-research-downgrades-top-glove-neutral-esg-concerns



Revision :-

Macquarie - TP : 5.45

JP Morgan - TP : 3.50

PB IB - TP : 7.30



-----------------------------------------------------------------------------------------------------------------



Keyman188 comment is only for those need to heard & perceive...


Save your hard earned money to avoid fighting with Big Funds...


Sometime need to follow the "wind" where to come...where to blow....

November exports 4.3% higher at RM84.43b — MITI

(theedgemarkets.com / December 28, 2020 11:43 am +08)

KUALA LUMPUR (Dec 28): Malaysia’s exports increased by 4.3% year-on-year (y-o-y) to RM84.43 billion in November 2020, from RM80.95 billion previously, as the country registered the third consecutive month of y-o-y growth.

In a statement today, the Ministry of International Trade and Industry (MITI) said the higher figure for November 2020 was due to higher exports to the US, Singapore, China and Hong Kong.

Meanwhile, imports in November were down 9% y-o-y at RM67.61 billion, from RM74.26 billion previously. Total trade contracted by 2% to RM152.04 billion from RM155.21 billion in November 2019.

The trade surplus amounted to RM16.82 billion after surging by 151.6%, the highest figure recorded thus far for the month of November.

Compared to October 2020, total trade, exports, imports and the trade surplus declined by 5%, 7.3%, 1.9% and 24% respectively.

For the cumulative 11 months of 2020 (11M20), the trade surplus grew 23.1% to RM163.86 billion from RM133.11 billion previously. Total trade was valued at RM1.61 trillion after falling from RM1.68 trillion a year ago. Exports stood at RM885.02 billion, contracting by 2.6%, while imports amounted to RM721.16 billion, falling by 7%.

MITI noted that in November 2020, exports of manufactured goods contributed to 88.1% of total exports and also rose by 81.% y-o-y to RM74.34 billion. The growth was driven by higher exports of electrical and electronics (E&E) products as well as rubber products, which according to the ministry had been resilient with 13 consecutive months of growth. Higher exports were also registered for other manufactures, especially solid-state storage devices (SSD), wood products as well as optical and scientific equipment.

The ministry also noted that agriculture goods, accounting for 6.7% of exports, increased by 6% y-o-y to RM5.65 billion on higher exports of palm oil and palm oil-based agriculture products.

Meanwhile, mining goods, showing a 4.9% contribution, contracted by 34.6% y-o-y to RM4.15 billion, following lower exports of liquefied natural gas (LNG), crude petroleum as well as petroleum condensates and other petroleum oil.

For 11M20, exports of manufactured goods slipped by 0.3% to RM765.63 billion, from 11M19, on lower exports of petroleum productions, chemicals and chemical products, on top of lower metal manufacturing.

“Meanwhile, higher exports were recorded for rubber products, E&E products, other manufactures (SSD), iron and steel products as well as optical and scientific equipment. Exports of agriculture goods grew by 5% to RM63.32 billion, attributed mainly to higher exports of palm oil and palm oil-based agriculture products. Exports of mining goods fell by 29.7% to RM52.21 billion due to lower exports of LNG, crude petroleum as well as petroleum condensates and other petroleum oil,” MITI said.

Trade with Asean stood at RM38.77 billion or 25.5% of total trade, falling by 7.2% from November 2019. Regional exports were down by 2.2% to RM23.46 billion, following lower exports of petroleum products, iron and steel products, as well as machinery, equipment and parts. However, exports of E&E products, increasing by 36.6% or RM2.6 billion, cushioned the decline. Imports from Asean dropped by 13.9% to RM15.31 billion.

Among the Asean markets, exports to Singapore expanded by RM1.78 billion, contributed by E&E products, while exports to Brunei rose by RM39 million, contributed by iron and steel products.

Meanwhile, trade with China in November rose by 3.2% y-o-y to RM30.06 billion, accounting for 19.8% of Malaysia’s total trade. Exports to China grew 13.2% to RM14.23 billion on on higher exports of E&E products.Imports from China was down by 4.5% to RM15.83 billion.

Trade to the US in November amounted to 10.1% of Malaysia’s total trade, rising by 8.6% y-o-y to RM15.42 billion. Exports to the US recorded a double digit growth for six consecutive months, surged by 24.6% to RM9.76 billion in November 2020. Higher exports were recorded for rubber products, E&E products, and wood products. Imports from the US contracted by 11.1% to RM5.66 billion.

Total trade with the EU, which accounted for 7.7% of Malaysia’s November traded fell by 4.9% y-o-y to RM11.64 billion. Exports continued to expand for three consecutive months, expanding by 7.1% to RM6.89 billion contributed mainly by higher exports of rubber products. Imports from the EU shrank by 18.2% to RM4.75 billion.

Cont...


## https://www.theedgemarkets.com/article/november-exports-43-higher-rm8443b-%E2%80%94-miti

Trump signs Covid relief and government funding bill days after he suggested he would block it

(PUBLISHED SUN, DEC 27 20208:13 PM ESTUPDATED SUN, DEC 27 20208:46 PM EST)

~ President Donald Trump signs a coronavirus relief and government funding package into law.

~ He refused to approve the legislation for days after receiving it from Congress, blowing past a deadline to prevent an estimated 14 million people from temporarily losing unemployment benefits.

~ Trump said the House and Senate will vote on increasing direct payments in the package to $2,000, though it is unclear if the GOP-held Senate will take up the measure.


President Donald Trump signed a massive coronavirus relief and government funding package into law Sunday, days after he sent Washington into a panic by suggesting he could veto the bill.

He refused to approve the legislation for days after receiving it, blowing past a Saturday deadline to prevent an estimated 14 million people from temporarily losing unemployment insurance. The measure extends the expanded jobless benefits into March, but millions of people are expected to lose a week of benefits due to Trump’s delay in signing the bill.

The government would have shut down Tuesday during a deadly pandemic if Trump did not approve the legislation.

The president called the bill a “disgrace” on Tuesday night — after Congress already approved it following talks which included his Treasury Secretary Steven Mnuchin. Trump claimed he opposed the bill because it included $600 rather than $2,000 direct payments to most Americans, and because the $1.4 trillion government spending portion of the package included foreign aid money. The president’s own White House has included those funds in its budgets.

After Trump expressed support for larger checks, Democrats embraced his stance. The Democratic-held House plans to vote on a measure to increase the payments to $2,000 on Monday.

In a statement Sunday night, Trump said the Senate would also “start the process for a vote that increases checks to $2,000.” Senate Majority Leader Mitch McConnell, in a separate statement cheering the bill becoming law, did not mention any plans to take up the legislation if the House passes it. Most members of the Kentucky Republican’s caucus have opposed larger direct payments.

The president also said he will send Congress a “formal rescission request” asking for what he called “wasteful items” to be removed from the bill. Lawmakers may not cancel the previously approved money, as the legislation passed both chambers of Congress with overwhelming bipartisan support.

The White House had signaled for weeks that Trump would sign whatever pandemic aid bill the divided Congress passed into law. His threat to oppose the legislation shocked Capitol Hill and sent Americans scrambling to adjust their plans.

Airlines, for instance, had moved to bring employees back with $15 billion in payroll assistance included in the bill.

Many economists and lawmakers have called the $900 billion coronavirus relief package inadequate. Still, it will send a dose of needed help to the country as the virus overwhelms the health-care system and economy.

The measure adds a $300 per week federal unemployment supplement through mid-March. It temporarily expands programs that made freelance and gig workers eligible for jobless benefits and added to the number of weeks jobless Americans can receive aid.

It sends $600 direct payments to most individuals, and adds $600 for every child. The legislation includes another round of small business assistance, most of which comes from $284 billion in forgivable Paycheck Protection Program loans.

It puts nearly $30 billion into distributing Covid-19 vaccines and ensuring Americans can get shots for free. The measure also directs more than $20 billion to state Covid-19 testing and contact tracing efforts.

Along with extending the eviction moratorium, it puts $25 billion into rental assistance. The airline payroll assistance is part of more than $45 billion in transportation relief.

The package also directs $82 billion to K-12 and higher education.

Democrats have said they will quickly push for another relief bill, headlined by direct payments and state and local government aid, after President-elect Joe Biden takes office on Jan. 20. Their ability to pass a bill will in part depend on whether Republicans keep control of the Senate in two Jan. 5 runoffs in Georgia.


## https://www.cnbc.com/2020/12/28/trump-signs-covid-relief-and-government-funding-bill-days-after-suggesting-hed-block-it.html

Keyman188 not the professional or expertise...Let the expertise give more advise to the market...

为什么想投资科技股就必须关注美国大选最终结果？马股橱窗粉饰之后会有调整吗？ - 陈剑

##https://klse.i3investor.com/blogs/kianweiaritcles/2020-12-26-story-h1538398268.jsp


业绩这么好为何股价涨不动？近期手套股业绩和股价走势背离最完整讲解！- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-20-story-h1536526427.jsp


新冠疫苗面世后，股市里的聪明钱会去哪里？对手套板块有多大影响？- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-14-story-h1536429185.jsp

-----------------------------------------------------------------------------------------------------------------


That's reason why some investment banks (IB) had started to revise glove sector outlook.........



Hereby to enclose the latest glove preview & outlook by IB...


Macquarie downgrades Top Glove to 'underperform', halves target price as earnings could normalise in 2H21

(theedgemarkets.com / September 10, 2020 17:36 pm +08)

##https://www.theedgemarkets.com/article/macquarie-downgrades-top-glove-underperform-halves-target-price-earnings-could-normalise




JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

(theedgemarkets.com / December 12, 2020 00:16 am +08)

##https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle




PublicInvest Research downgrades Top Glove to 'neutral' on ESG concerns

(theedgemarkets.com / December 18, 2020 10:38 am +08)

##https://www.theedgemarkets.com/article/publicinvest-research-downgrades-top-glove-neutral-esg-concerns



Revision :-

Macquarie - TP : 5.45

JP Morgan - TP : 3.50

PB IB - TP : 7.30



-----------------------------------------------------------------------------------------------------------------



Keyman188 comment is only for those need to heard & perceive...


Save your hard earned money to avoid fighting with Big Funds...


Sometime need to follow the "wind" where to come...where to blow....

Keyman188 not the professional or expertise...Let the expertise give more advise to the market...

为什么想投资科技股就必须关注美国大选最终结果？马股橱窗粉饰之后会有调整吗？ - 陈剑

##https://klse.i3investor.com/blogs/kianweiaritcles/2020-12-26-story-h1538398268.jsp


业绩这么好为何股价涨不动？近期手套股业绩和股价走势背离最完整讲解！- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-20-story-h1536526427.jsp


新冠疫苗面世后，股市里的聪明钱会去哪里？对手套板块有多大影响？- 陈剑
## https://klse.i3investor.com/blogs/kianweiaritcles/2020-11-14-story-h1536429185.jsp

-----------------------------------------------------------------------------------------------------------------


That's reason why some investment banks (IB) had started to revise glove sector outlook.........



Hereby to enclose the latest glove preview & outlook by IB...


Macquarie downgrades Top Glove to 'underperform', halves target price as earnings could normalise in 2H21

(theedgemarkets.com / September 10, 2020 17:36 pm +08)

##https://www.theedgemarkets.com/article/macquarie-downgrades-top-glove-underperform-halves-target-price-earnings-could-normalise




JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

(theedgemarkets.com / December 12, 2020 00:16 am +08)

##https://www.theedgemarkets.com/article/jp-morgan-pegs-these-glove-makers-fair-value-half-their-market-price-says-supernormal-cycle




PublicInvest Research downgrades Top Glove to 'neutral' on ESG concerns

(theedgemarkets.com / December 18, 2020 10:38 am +08)

##https://www.theedgemarkets.com/article/publicinvest-research-downgrades-top-glove-neutral-esg-concerns



Revision :-

Macquarie - TP : 5.45

JP Morgan - TP : 3.50

PB IB - TP : 7.30



-----------------------------------------------------------------------------------------------------------------



Keyman188 comment is only for those need to heard & perceive...


Save your hard earned money to avoid fighting with Big Funds...


Sometime need to follow the "wind" where to come...where to blow....

Today glove sector selling pressure due to the following news...


## https://www.freemalaysiatoday.com/category/nation/2020/12/27/global-glove-importers-rethink-relationship-with-malaysian-manufacturer/


PETALING JAYA: Two key global glove importers are re-evaluating their relationship with a Malaysian glove manufacturer after government raids uncovered abysmal foreign worker accommodations at two of its subsidiaries.

Kimberly-Clark, the American personal care giant behind household brands such as Kleenex, Scott and Huggies, told FMT it was “evaluating the matter” when asked whether it would continue to source from the company.

Meanwhile, Ansell, an Australian safety and personal protection firm which supplies the UK’s National Health Service, said it was planning to meet the company’s managing director “as quickly as possible” to decide on the consequences of this “unacceptable situation”.

A multi-agency operation at one of the factories on Monday found 781 workers living behind the building in two blocks of shipping containers stacked three storeys high. A separate raid on its sister company on Thursday found workers crammed into two warehouses at either end of a pathway filled with mountains of garbage and factory waste.

“We were shocked to see such living conditions (in the first factory), which are absolutely unacceptable,” said an Ansell spokesperson.

“Based on the photos and video included in the media reports, it is evident that the living conditions provided for some workers at the site are unacceptable and are a violation of Ansell’s ethical labour standards, human rights statement and supplier code of conduct.”

The company also said it was in contact with other suppliers to determine alternatives and ensure it continued to meet the increased global demand for personal protective equipment during the Covid-19 pandemic.

Insisting it was “absolutely not” aware of the living conditions at the first factory, Ansell said a third party audit ordered by the company in May 2019 did not reveal the foreign workers’ dismal living conditions.

Be more alert....

Seem today glove sector heavily selling pressure due to this news...

U.S. Cases Slow in Holiday Amid Warnings of Worse: Virus Update
Bloomberg News

(December 27, 2020, 7:52 AM GMT+8 Updated on December 28, 2020, 5:53 AM GMT+8)

Top U.S. health officials warned of a post-Christmas surge in infection, as new cases slowed amid scattered holiday reporting from states. Total infections passed 19 million. New York state’s new infections dipped, as did holiday testing. North Carolina hospitalizations hit a record, while South Carolina reported record infections.

A coordinated vaccination campaign was underway in Europe, just days after the EU cleared a shot developed by Pfizer Inc. and BioNTech SE. Italy and France were among the first of the bloc’s 27 member states to start inoculations. In Germany, which began a day early, the rollout was postponed in some cities after doubts emerged about whether the shots had been kept cold enough during transit.

Concern about the mutated strain first detected in Britain grew in Asia. China asked airlines to suspend passenger flights with the U.K. from Dec. 28 to Jan. 10. Norway reported two cases of the variant.


## https://www.bloomberg.com/news/articles/2020-12-26/mutant-strain-spreads-n-j-records-worst-month-virus-update?srnd=premium-asia


---------------------------------------------------------------------------------------------------------

Daily infections - US:-

27/12/20 - 150,572

26/12/20 - 188,667

25/12/20 - 190,678

24/12/20 - 206,925

23/12/20 - 213,610

22/12/20 - 214,735

21/12/20 - 214,952

20/12/20 - 217,074

19/12/20 - 215,842

18/12/20 - 218,891

'The beginning of the end': Europe rolls out vaccines to fight pandemic

(December 27, 2020 21:30 pm +08)

MADRID/ROME/LISBON/VIENNA/PRAGUE/SOFIA/ZAGREB/OSLO/ATHENS/PARIS (Dec 27): Europe launched a mass Covid-19 vaccination drive on Sunday, with pensioners and medics lining up to get the first shots to see off a pandemic that has crippled economies and claimed more than 1.7 million lives worldwide.

"Thank God," 96-year-old Araceli Hidalgo said as she became the first person in Spain to have a vaccine at her care home in Guadalajara near the capital Madrid. "Let's see if we can make this virus go away."

In Italy, the first country in Europe to record significant numbers of infections, 29-year-old nurse Claudia Alivernini was one of three medical staff at the head of the queue for the shot developed by Pfizer and BioNTech.

"It is the beginning of the end ... it was an exciting, historic moment," she said at Rome's Spallanzani hospital.

The region of 450 million people is trying to catch up with the United States and Britain which have both already started vaccinations using the Pfizer/BioNTech shot.

The EU is due to receive 12.5 million doses of the shot by the end of the year, enough to vaccinate 6.25 million people based on the two-dose regimen. The companies are scrambling to meet global demand and aim to make 1.3 billion shots next year.

Europe has secured contracts with a range of drugmakers besides Pfizer including Moderna and AstraZeneca , for a total of more than two billion vaccine doses and has set a goal for all adults to be inoculated during 2021.

While Europe has some of the best-resourced healthcare systems in the world, the sheer scale of the effort means some countries are calling on retired medics to help, while others have loosened rules for who is allowed to give the injections.

With surveys pointing to high levels of hesitancy towards the vaccine in countries from France to Poland, leaders of the 27-country European Union are promoting it as the best chance of getting back to something like normal life next year.

"We have a new weapon against the virus: the vaccine. We must stand firm, once more," tweeted French President Emmanuel Macron, who tested positive for the coronavirus this month and left quarantine on Christmas Eve.

Solar-powered pavilions
After European governments were criticised for failing to work together to counter the spread of the virus in early 2020, the goal this time is to ensure that there is equal access to the vaccines across the region.

But even then, Hungary on Saturday jumped the gun on the official roll-out by administering shots to frontline workers at hospitals in the capital Budapest.

Slovakia also went ahead with some inoculations of healthcare staff on Saturday and in Germany, a small number of people at a care home were inoculated a day early too.

"We don't want to waste that one day that the vaccine loses shelf life," Karsten Fischer, from the pandemic staff of the Harz district in the German state of Saxony-Anhalt, told local broadcaster MDR.

The distribution of the shot presents tough challenges as the vaccine uses new mRNA technology and must be stored at ultra-low temperatures of about -70 degrees Celsius (-112°F).

In Germany, several vaccination centres in Northern Bavaria held off from inoculating people after uncertainty arose on whether the cold chain had been maintained. "When reading the temperature loggers that were enclosed in the cool boxes, doubts arose about the compliance with the cold chain requirements", the vaccination centres of Coburg, Lichtenfels, Kronach, Kulmbach, Hof, Bayreuth and Wunsiedel said in a joint statement.

The Pfizer shots being used in Europe were shipped from its factory in Puurs, Belgium, in specially designed containers filled with dry ice. They can be stored for up to six months at Antarctic winter temperatures, or for five days at 2C to 8C, a type of refrigeration commonly available at hospitals.

Beyond hospitals and care homes, sports halls and convention centres left vacant by lockdown restrictions will become venues for mass inoculations.

In Italy, temporary solar-powered healthcare pavilions designed to look like five-petalled primrose flowers — a symbol of spring — sprouted in town squares.

Cont...


## https://www.theedgemarkets.com/article/europe-rolls-out-vaccines-bid-leave-pandemic-behind

KLCI futures expected to trade higher next week

(December 26, 2020 10:03 am +08)

KUALA LUMPUR (Dec 26): The FTSE Bursa Malaysia KLCI (FBM KLCI) futures contract is expected to trade higher next week as investors take the cue from the bullish underlying cash market.

Inter-Pacific Asset Management Sdn Bhd chief executive officer Datuk Dr Nazri Khan Adam Khan expects the benchmark FBM KLCI to test the psychological level of 1,700 amidst window-dressing activities and improved market sentiment.

He said the key index is poised to march into the new year on a high note, riding on the ‘Santa Claus’ rally as investors turn bullish towards year-end.

“Traditionally, the last week of December and the first week of new year are the strongest weeks of the year, therefore I believe KLCI will move higher between 1,680 and 1,700,” he told Bernama.

On a Friday-to-Thursday basis, spot month December 2020 reduced 12.5 points to 1,641.0, January 2021 eased 11.0 points to 1,639.0, March 2021 decreased 13.0 points 1,639.0 and June 2021 shed 10.5 points to 1,634.0.

Turnover increased to 50,009 lots from 49,700 lots last week, while open interest widened to 43,821 contracts from 38,750 contracts previously.

The FBM KLCI decreased 11.32 points to 1,641.17 on Thursday from 1,652.49 on Friday last week.

## https://www.theedgemarkets.com/article/klci-futures-trade-higher-next-week

Lol...seem like got traders started to hot ready...cheers...


So tomorrow make it super hot again....


Gammateh...keep it up super hot...,


Wkwkwk...kekeke...

Post removed.Why?

Kesian...kesian...

You want to look down look up also nothing to do with Keyman188 lahhh...


More important things Keyman188 nothing to lose...


Wkwkwk...kekeke...

Aiya...you pakai big car... living big house...nothing to do with Keyman188 lahh...

You untung or rugi also nothing to do with Keyman188 lahhh...

Keyman188 always like to remind "newbies" on...


Wkwkwk...kekeke...

So we need to monitor closely how will be market reaction tomorrow...

Yaya...Keyman188 really very broke & poor...

Other people driving big car...Keyman188 just cycling small bicycle every....

Bingo....you are right.....Keyman188 definitely very very broke & poor...

Please....tolong tolong....Keyman188 below B40 only...

Bagi sikit suap makan....kekeke

Post removed.Why?